Prophylaxis of bipolar disorder: How and who should we treat in the long term?

European Neuropsychopharmacology

Volumn 9, Issue SUPPL. 4, 1999, Pages

  Goodwin, G M ^a  

^a WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

Bipolar disorder; Compliance; Mood stabilisers; Neuroleptics; Prophylaxis; Trial design

Indexed keywords

LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT;

CONFERENCE PAPER; HUMAN; MANIA; MANIC DEPRESSIVE PSYCHOSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROPHYLAXIS;

AFFECT; ANTIMANIC AGENTS; BIPOLAR DISORDER; CLINICAL TRIALS; EUROPE; HUMANS; LITHIUM CHLORIDE; PATIENT COMPLIANCE; UNITED STATES;

EID: 0032782397     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(99)00026-7     Document Type: Conference Paper

References (38)

1. Adityanjee. The syndrome of irreversible lithium-effectuated neurotoxicity (SILENT). Pharmacopsychiatry. 22:1989;81-83.
2. Practice guideline for the treatment of patients with bipolar disorder. Am. J. Psychiatry. 151:(Suppl. 12):1994;1-36.
3. Berk, M., 1999. Lamotrigine and the treatment of mania in bipolar disorder. Eur. Neuropsychopharmacol. (this issue).
4. Bowden C.L. New concepts in mood stabilization: evidence for the effectiveness of valproate and lamotrigine. Neuropsychopharmacology. 19:1998;194-199.
5. Bowden, C.L., Mitchell, P., Suppes, T., 1999. Lamotrigine in the treatment of bipolar depression. Eur. Neuropsychopharmacol. (this issue).
6. Bowden C.L., Brugger A.M., Swann A.C., Calabrese J.R., Janicak P.G., Petty F., Dilsaver S.C., Davis J.M., Rush A.J., Small J.G. Efficacy of divalproex vs. lithium and placebo in the treatment of mania. The Depakote Mania Study Group. J. Am. Med. Assoc. 271:1994;918-924.
7. Calabrese J.R., Rapport D.J., Shelton M.D., Kujawa M., Kimmel S.E. Clinical studies on the use of lamotrigine in bipolar disorder. Neuropsychobiology. 38:1998;185-191.
8. Calabrese J.R., Bowden C.L., Sachs G.S., Ascher J.A., Monaghan E., Rudd G.D. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J. Clin. Psychiatry. 60:1999;79-88.
9. Cookson J.C. Lithium: balancing risks and benefits. Br. J. Psychiatry. 171:1997;120-124.
10. Coxhead N., Silverstone T., Cookson J. Carbamazine versus lithium in the prophylaxis of bipolar affective disorder. Acta. Psychiatr. Scand. 85:1992;114-118.
11. Dickson W.E., Kendell R.E. Does maintenance lithium therapy prevent recurrences of mania under ordinary clinical conditions? Psychol. Med. 16:1986;521-530.
12. Fatemi S.H., Rapport D.J., Calabrese J.R., Thuras P. Lamotrigine in rapid-cycling bipolar disorder. J. Clin. Psychiatry. 58:1997;522-527.
13. Frances A., Docherty J.P., Kahu D.A. The Expert Consensus Guideline series: treatment of bipolar disorder. J. Clin. Psychiatry. 57:(Suppl. 12A):1996;1-88.
14. Frances A.J., Kahn D.A., Carpenter D., Docherty J.P., Donovan S. The Expert Consensus Guidelines for treating depression in bipolar disorder. J. Clin. Psychiatry. 59:(Suppl. 4):1998;73-79.
15. Goodwin F.K., Murphy D.L., Bunney W.F. Jr. Lithium carbonate treatment in depression and mania: a longitudinal double-blind study. Arch. Gen. Psychiatry. 21:1969;486-496.
16. Goodwin G.M. Recurrence of mania after lithium withdrawal: implications for the use of lithium in the treatment of bipolar affective disorder. Br. J. Psychiatry. 164:1994;149-152.
17. Hill R.G., Hardy P., Shephard G. Perspectives on Manic Depression. 1996;The Sainsbury Centre for Mental Health, London.
18. Johnson R.E., McFarland B.H. Lithium use and discontinuation in a health maintenance organization. Am. J. Psychiatry. 153:1996;993-1000.
19. Keck P.E. Jr., McElroy S.L., Strakowski S.M., Bourne M.L., West S.A. Compliance with maintenance treatment in bipolar disorder. Psychopharmacol. Bull. 33:1997;87-91.
20. Keck P.E. Jr., McElroy S.L., Strakowski S.M. Anticonvulsants and antipsychotics in the treatment of bipolar disorder. J. Clin. Psychiatry. 59:(Suppl. 6):1998;74-81.
21. Keller M.B., Lavori P.W., Kleerman G.L., Andreasen N.C., Endicott J., Coryell W., Fawcett J., Rice J.P., Hirschfeld R.M. Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients. Arch. Gen. Psychiatry. 43:1986;458-466.
22. Kusumakar V., Yatham L.N. An open study of lamotrigine in refractory bipolar depression. Psychiatry Res. 72:1997;145-148.
23. Licht R.W., Gouliaev G., Vestergaard P., Dybbro J., Lund H., Merinder L. Treatment of manic episodes in Scandinavia: the use of neuroleptic drugs in a clinical routine setting. J. Affect. Disord. 32:1994;179-185.
24. Lusznat R.M., Murphy D.P., Nunn C.M. Carbamazepine vs. lithium in the treatment and prophylaxis of mania. Br. J. Psychiatry. 153:1988;198-204.
25. Maggs R. Treatment of manic illness with lithium carbonate. Br. J. Psychiatry. 109:1963;56-65.
26. Maj M., Pirozzi R., Magliano L., Bartoli L. Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic. Am. J. Psychiatry. 155:1998;30-35.
27. Mander A.J. Is there a lithium withdrawal syndrome? Br. J. Psychiatry. 149:1986;498-501.
28. Mander A.J., Loudon J.B. Rapid recurrence of mania following abrupt discontinuation of lithium. Lancet. ii:(8601):1988;15-17.
29. Mangano W.E., Montine T.J., Hulette C.M. Pathologic assessment of cerebellar atrophy following acute lithium intoxication. Clin. Neuropathol. 16:1997;30-33.
30. Marcus W.L. Lithium: a review of its pharmacokinetics, health effects, and toxicology. J. Environ. Pathol. Toxicol. Oncol. 13:1994;73-79.
31. Peto R., Baigent C. Trials: the next 50 years. Br. Med. J. 317:1998;1170-1171.
32. Peto R., Collins R., Gray R. Large-scale randomized evidence: large, simple trials and overviews of trials. J. Clin. Epidemiol. 48:1995;23-40.
33. Post R.M., Denicoff K.D., Frye M.A., Dunn R.T., Leverich G.S., Osuch E., Speer A. A history of the use of anticonvulsants as mood stabilizers in the last two decades of the 20th century. Neuropsychobiology. 38:1998;152-166.
34. Reetz-Kokott U., Muller-Oerlinghausen B. Has drug treatment of manic disorders changed in clinical routine practice? Retrospective analysis of treatment modalities and results in a university psychiatric clinic. Nervenarzt. 67:1996;229-234.
35. Schou M., Nielson J., Strömgren E., Voldby H. Treatment of manic psychoses by administration of lithium salts. J. Neurol. Neurosurg. Psychiatr. 17:1954;250-260.
36. Stokes P.E., Shamoian C.A., Stoll P.M., Patton M.J. Efficacy of lithium as acute treatment of manic-depressive illness. Lancet. i:1971;1319-1325.
37. Tondo L., Jamison K.R., Baldessarini R.J. Effect of lithium maintenance on suicidal behavior in major mood disorders. Ann. NY Acad. Sci. 836:1997;339-351.
38. Walden J., Normann C., Langosch J., Berger M., Grunze H. Differential treatment of bipolar disorder with old and new antiepileptic drugs. Neuropsychobiology. 38:1998;181-184.